MAOB and neoplasm: Working on the premise that increased catecholamine activity in the brain might prevent the development of mammary and pituitary tumors, Thyagarajan et al. demonstrated a reduced incidence of these neoplasms in acyclic female rats undergoing long-term treatment with deprenyl, the selective irreversible MAO-B inhibitor [77].